The UK government wants to expand its scientific partnership with Brazil’s research organization Fiocruz, especially in fields such as genomic sequencing, declared the minister counsellor of the British Embassy in Brazil, Melanie Hopkins, during a meeting with Fiocruz president Nísia Trindade Lima.
"It was very important to come here and sit down face-to-face with these scientists. The first steps in the partnership [on the vaccine] were taken during the estrangement period, in what was historic work. I am happy to know that we will continue to work together," said Ms Hopkins, showing a willingness to establish partnerships with the Foundation's various units around the country. "The fact that this is my first external event in Brazil demonstrates the importance of Fiocruz."
At the meeting, Marilda Siqueira highlighted the contribution of British institutions and researchers in the development of the Respiratory Virus and Measles Laboratory, headed by her, at the Oswaldo Cruz Institute (IOC). Part of the Genomics Network at Fiocruz, the unit receives samples from other countries, such as Haiti and Honduras, and also participates in the foreign researchers training.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze